InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
T+90 hit rate
22%
T+90 mean return
-9.0%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Culley Brian M, Président et CEO. Officer active across 1 company, notably Lineage Cell Therapeutics, Inc.. Cumulatively, 14 reports have been published. Split: 3 buys · 0 sell. Total volume traded: €39k. History available since 28 June 2021. The latest transaction was disclosed on 21 November 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
31,249 sharesCommon SharesSEC:0000950170-25-018887:0
40,000 shares@ US$0.605.9% of flowCommon SharesSEC:0000950170-24-129972:0
Ideal exit: 18 Aug 2025 (T+270)
10,000 shares@ US$1.052.5% of flowCommon SharesSEC:0000950170-24-064896:0
Ideal exit: 18 Feb 2025 (T+270)
31,249 sharesCommon Shares, no par valueSEC:0001493152-24-005942:0
31,249 sharesCommon Shares, no par valueSEC:0001493152-23-004898:0
15,450 sharesCommon Shares, no par valueSEC:0001493152-22-018271:0
15,450 sharesCommon Shares, no par valueSEC:0001493152-22-009000:0
5,250 shares@ US$1.380.0016% mcap1.9% of flowCommon Shares, no par valueSEC:0001493152-22-007925:0
Ideal exit: 20 Dec 2022 (T+270)
15,450 sharesCommon Shares, no par valueSEC:0001493152-22-000116:0
15,450 sharesCommon Shares, no par valueSEC:0001493152-22-000116
15,450 sharesCommon Shares, no par valueSEC:0001493152-21-025197:0
15,450 sharesCommon Shares, no par valueSEC:0001493152-21-025197
300,000 shares@ US$0.691945.0% of flowCommon Shares, no par valueSEC:0001493152-21-015778
300,000 shares@ US$0.69190.043% mcap49.1% of flowCommon Shares, no par valueSEC:0001493152-21-015778:0
14 of 14 declarations
About Culley Brian M
Brian M. Culley is President and CEO at Lineage Cell Therapeutics, Inc. He is responsible for the overall direction and strategy of the company. His role is essential in guiding Lineage in its initiatives and ensuring its growth.
